Invitro International
InVitro International, Inc. develops test kits for non-animal testing applications in the United States and internationally. Its products include Irritection Assay System, an invitro test, which utilizes the change of relevant macromolecules to predict the ocular and dermal irritancy of chemicals, mixtures, and product formulations; and Corrositex, a non-animal test that determines skin corrosivi… Read more
Invitro International (IVRO) - Total Liabilities
Latest total liabilities as of March 2024: $55.00K USD
Based on the latest financial reports, Invitro International (IVRO) has total liabilities worth $55.00K USD as of March 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Invitro International - Total Liabilities Trend (1989–2023)
This chart illustrates how Invitro International's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Invitro International Competitors by Total Liabilities
The table below lists competitors of Invitro International ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Malvern International
LSE:MLVN
|
UK | GBX13.30 Million |
|
Quality Hospitality Leasehold Property Fund
BK:QHOP
|
Thailand | ฿3.03 Million |
|
AGROWILL GROUP
MU:W9Z
|
Germany | €172.99 Million |
|
Ghandhara Tyre and Rubber Company Ltd
KAR:GTYR
|
Pakistan | PKRs13.10 Billion |
|
Marquie Group Inc
PINK:TMGI
|
USA | $6.88 Million |
|
CPPGroup Plc
LSE:CPP
|
UK | GBX22.06 Million |
Liability Composition Analysis (1989–2023)
This chart breaks down Invitro International's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 27.85 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.04 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.03 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Invitro International's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Invitro International (1989–2023)
The table below shows the annual total liabilities of Invitro International from 1989 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-09-30 | $78.99K | +15.76% |
| 2022-09-30 | $68.24K | -66.15% |
| 2021-09-30 | $201.61K | -4.97% |
| 2020-09-30 | $212.16K | +37.70% |
| 2019-09-30 | $154.07K | +107.90% |
| 2017-09-30 | $74.11K | -0.35% |
| 2008-09-30 | $74.37K | +19.48% |
| 2007-09-30 | $62.24K | -84.44% |
| 1996-09-30 | $400.00K | 0.00% |
| 1995-09-30 | $400.00K | -55.56% |
| 1994-09-30 | $900.00K | +12.50% |
| 1993-09-30 | $800.00K | -27.27% |
| 1992-09-30 | $1.10 Million | +266.67% |
| 1991-09-30 | $300.00K | -84.21% |
| 1990-09-30 | $1.90 Million | +72.73% |
| 1989-09-30 | $1.10 Million | -- |